SymBio Pharmaceuticals Limited

¥68.00As of Sun 8 Nov 2026, 12:00 UTC
TSE:4582Healthcare
Country Japan
PE (Fwd) •••
TSR 10Y CAGR (23.09%)
Div yield —
ROE (3414.20%)
Medical (Pharmaceuticals)
Beta (5Y) 0.69
PE TTM —
TSR TTM (41.88%)
Mkt cap ¥5.743B
ROIC (1477.87%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥73
7.33%
(89.64%)
Hold 7|3|1|6|12
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
1.56
1.59
1.69
1.77
9.58%
15.82%
17.99%
11.10%
Revenue¥M
555.4
557.5
552.0
584.1
1.04%
3.31%
0.31%
4.38%
Peers (US$36.46M)
Cap (US$)
PE
67.70M
—
36.76M
62.21x
19.91M
17.69x
45.63M
35.27x
Capital
TTM
5Y
10Y
Leveragex
7.473
(0.123)
(0.126)
EBIT/Intx
4.815
0.264
0.237
Own earn%
(143.51)
66.13
68.08
Sh yield%
23.24
6.67
7.72
Owners
Insiders/Inst%
1.83
32.02
Short interest%
0.57
SBC / revenue%
3.70
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
10
Op margin range%
0–6
$1 testx
40.9
Incr. ROIC%
49